Buy Semaglutide in Israel
Semaglutide is the most extensively studied GLP-1 receptor agonist. The STEP programme (6 Phase 3 trials) demonstrated 14.9–17% mean body weight reduction over 68 weeks. QSC ships to Israel from the EU regional warehouse in 5–8 business days. Israel spends approximately 5% of GDP on R&D — the world's highest ratio — with the Weizmann Institute, Technion, Hebrew University, TAU, and BGU all maintaining active research programmes in GLP-1 Receptor Agonist and related fields.
Semaglutide (CAS 910463-68-2): Semaglutide (CAS 910463-68-2, MW 4113.6 Da) is a GLP-1 analogue with 94% homology to native GLP-1. Binds GLP-1R in pancreatic beta cells (insulin secretion), hypothalamus (appetite suppression) and intestine (delayed gastric emptying). C18 fatty acid conjugation enables albumin binding, extending half-life to approximately 7 days. QSC supplies research-grade Semaglutide at >=99% HPLC purity, Janoshik COA. Order at qscpeptide.com.
Buy Semaglutide — EU Warehouse to Israel
₪185 / USD 50 · 5–8 business days nationwide. >=99% HPLC, Janoshik COA. Bitcoin and USDT accepted.
Buy Semaglutide at QSC →Israel Shipping Details
| Destination | Delivery Time |
|---|---|
| Tel Aviv / Gush Dan / Rehovot | 5–8 business days |
| Jerusalem / Modi'in / Beit Shemesh | 6–9 business days |
| Haifa / Technion corridor | 6–9 business days |
| Beersheba / South District | 6–10 business days |
| North District (Galilee, Golan) | 6–10 business days |
| Tracking number | All orders |
| Shipping cost | Free |
| Purity | >=99% HPLC |
| COA | Janoshik (independent) |
| Payment | Bitcoin / USDT |
| Pricing | ILS (₪) and USD listed |
Mechanism of Action
Semaglutide (CAS 910463-68-2, MW 4113.6 Da) is a GLP-1 analogue with 94% homology to native GLP-1. Binds GLP-1R in pancreatic beta cells (insulin secretion), hypothalamus (appetite suppression) and intestine (delayed gastric emptying). C18 fatty acid conjugation enables albumin binding, extending half-life to approximately 7 days.
Semaglutide — Research Data
STEP 1 (NCT03548935): 14.9% mean weight reduction vs 2.4% placebo at 68 weeks. STEP 5: maintenance to 104 weeks. Israeli researchers at Sheba Medical Center, Hadassah, and Rambam are active participants in international GLP-1 clinical trial networks. Israel's obesity rate — approximately 26% of adults — and its high prevalence of type 2 diabetes (particularly within the Arab-Israeli and ultra-Orthodox Jewish populations) make GLP-1 metabolic research a clinical priority.
Available Nationwide
QSC ships Semaglutide from the EU regional warehouse to all Israeli cities: Tel Aviv and Gush Dan, Rehovot (Weizmann Institute), Jerusalem (Hebrew University, Hadassah), Haifa (Technion, Rambam), Beersheba (BGU), and all northern, southern and central districts. Israel's world-class research institutions — Weizmann, Technion, HUJI, TAU, BGU, Bar-Ilan — all within the delivery window. ILS (₪) and USD pricing shown. Payment: Bitcoin (BTC) and USDT/USDC only.